DOI:
10.1055/s-00000077
Seminars in Thrombosis and Hemostasis
LinksClose Window
References
Eikelboom JW, O'Donnell M, Yusuf S , et al.
Rationale and design of AVERROES: apixaban versus acetylsalicylic acid to prevent stroke in atrial fibrillation patients who have failed or are unsuitable for vitamin K antagonist treatment.
Am Heart J 2010;
159 (3) 348 , e1
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.